Inter-individual variation in CYP2A6 activity and Chronic Obstructive Pulmonary Disease in smokers: perspectives for an early predictive marker.

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Biochimica et Biophysica Acta - Molecular Basis of Disease

• Publication date

  2020-10-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bbadis.2020.165990PMID 33091566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions

  2020cited by this paper
• Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers

  2020cited by this paper
• An Update on the Global Initiative for Chronic Obstructive Lung Disease 2017 Guidelines With a Focus on Classification and Management of Stable COPD

  2018cited by this paper
• The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL)

  2017cited by this paper
• Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study

  2016cited by this paper
• Upregulation of ICAM-1 and IL-1β protein expression promotes lung injury in chronic obstructive pulmonary disease.

  2016cited by this paper
• Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers

  2016cited by this paper
• The relevance of monitoring of antibodies against the polycyclic aromatic hydrocarbon (PAH) and PAH-DNA adducts in serum in relation to lung cancer and chronic obstructive pulmonary disease (COPD).

  2013cited by this paper
• Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.

  2013cited by this paper
• Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smoking.

  2012cited by this paper
• Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level

  2011cited by this paper
• Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products.

  2010cited by this paper
• Longer term exposure to secondhand smoke and health outcomes in COPD: impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

  2009cited by this paper
• Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.

  2004cited by this paper
• Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.

  1992cited by this paper

• Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality

  2024cites this paper
• The Impact of Different Smoking Behavior on Pulmonary Function and Pulmonary Hypertension Among Chinese Male Patients with Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET

  2024cites this paper
• Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis

  2023cites this paper
• Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

  2023cites this paper
• CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study

  2023cites this paper
• Short-Term Benefits of Smoking Cessation Improve Respiratory Function and Metabolism in Smokers

  2023cites this paper
• Respiratory Function, Physical Capacity, and Metabolic Syndrome Components in Combustible Cigarettes and Heated Tobacco Products Users: A Four-Year Follow-Up Cohort Study

  2022cites this paper
• Evaluation of Risk Factors for Chronic Obstructive Pulmonary Disease in the Middle-Aged and Elderly Rural Population of Northeast China Using Logistic Regression and Principal Component Analysis

  2022cites this paper
• Estimating the Health Effect of Cigarette Smoking Duration in South Africa

  2022cites this paper
• Smoking Cessation after Cancer Diagnosis and Enhanced Therapy Response: Mechanisms and Significance

  2022cites this paper
• Certified Smoking Cessation Units in Spain: High Potential for Detection of Undiagnosed Chronic Obstructive Pulmonary Disease and Profile of Newly Diagnosed Cases

  2021cites this paper
• Association between smoking cessation and obstructive spirometry pattern among Korean adults aged 40–79 years

  2021cites this paper
• Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort

  2021cites this paper
• Adherence and Efficacy of Smoking Cessation Treatment Among Patients with COPD in China

  2021cites this paper
• Genetic Factors Associated with COPD Depend on the Ancestral Caucasian/Amerindian Component in the Mexican Population

  2021cites this paper
• Ethnic Differences of Urinary Cadmium in Cigarette Smokers from the Multiethnic Cohort Study

  2021cites this paper